Impedimed Ltd (ASX:IPD)
A$ 0.053 0 (0%) Market Cap: 107.22 Mil Enterprise Value: 83.73 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 0/100

Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript

Jul 23, 2023 / 11:30PM GMT
Operator

Thank you for standing by. And welcome to the ImpediMed Limited quarterly results conference call. (Operator Instructions)

I would now like to hand the conference over to Mr. Rick Valencia, Managing Director and CEO. Please go ahead.

Richard P. Valencia
ImpediMed Limited - MD, CEO & Director

Thank you, Zach. Good morning, everyone, and thank you for joining us on our quarterly 4C call today. We had a strong close to our fiscal year 2023. As we suggested would happen after our inclusion in the NCCN Survivorship Guidelines, we're gaining significant momentum with private payers with our first top 5 national payer publishing medical policy in less than 5 months from our inclusion in the guidelines. In addition, our pipeline has never been richer and the level of customer engagement has markedly improved. For example, we closed on an 8 SOZO system deal in Michigan last quarter that was upsized at the last minute because of the significantly improved ROI we delivered after getting the critical mass in that market. That's just one example of the type of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot